
Nirglim MV 2/0.3 Tablet SR
Marketer
Nirvana India Pvt Ltd
Salt Composition
Glimepiride (2mg) + Metformin (500mg) + Voglibose (0.3mg)
Overview Nirglim MV 2/0.3 Tablet SR
Glimepiride and metformin combination tablets (2mg/300mg extended-release) are classified as antidiabetic agents. This dual-action medication manages type 2 diabetes in adults by regulating blood glucose. Administer this medication with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continuous use is crucial; discontinuation without medical supervision can elevate blood sugar, risking kidney complications, vision impairment, neuropathy, and limb loss. This medication complements a holistic approach encompassing diet, exercise, and weight management as directed by your healthcare provider. Lifestyle choices significantly impact diabetes control. Hypoglycemia (low blood sugar) is a prevalent side effect, characterized by sweating, dizziness, headache, and tremors. Maintain regular meals and carry a quick-acting glucose source (e.g., sugary snacks or juice). Alcohol consumption increases hypoglycemia risk and should be limited. Additional potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, edema, blurred vision, fractures, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Disclose any history of heart disease to your doctor prior to commencing treatment. Pregnant or lactating individuals should consult their physician before use. Regular blood glucose monitoring is essential, along with potential blood tests to assess blood cell counts and liver function.
Primary Ingredients of Nirglim MV 2/0.3 Tablet SR
No text was provided to rewrite. Please provide the text you wish to have rephrased.
Uses of Nirglim MV 2/0.3 Tablet SR
Managing Type 2 diabetes
Major Benefits of Nirglim MV 2/0.3 Tablet SR:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Swallow the Nirglim MV 2/0.3 Tablet SR whole; do not crush, chew, or break it. Administer on an empty stomach.
Common Side effects of Nirglim MV 2/0.3 Tablet SR:
- Nausea
- Diarrhea
- Abdominal pain
- Hypoglycemia (low blood glucose level)
- Loss of appetite
How to use Nirglim MV 2/0.3 Tablet SR:
Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Nirglim MV 2/0.3 Tablet SR on an empty stomach.
How Nirglim MV 2/0.3 Tablet SR works:
Nirglim MV 2/0.3 Extended-Release tablets contain a triple-action formulation for diabetes management.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent use of alcohol and Nirglim MV 2/0.3 Tablet SR is contraindicated.
PregnancyCONSULT YOUR DOCTOR
The use of Nirglim MV 2/0.3 Tablet SR during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential advantages against any possible risks prior to prescribing. Medical advice is recommended.
Breast feedingCONSULT YOUR DOCTOR
The extended-release Nirglim MV 2/0.3 Tablet likely poses a risk to breastfeeding infants. Available data from human studies indicate potential transfer to breast milk, potentially causing harm to the nursing child.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyUNSAFE
Patients with kidney impairment should likely avoid Nirglim MV 2/0.3 Tablet SR, as its use may be unsafe. Medical advice is recommended. The use of Nirglim MV 2/0.3 Tablet SR is contraindicated in those with severe kidney disease.
LiverCAUTION
Patients with liver impairment should use Nirglim MV 2/0.3 Tablet SR cautiously, potentially requiring dosage modification. Consultation with a physician is advised. A reduced initial dose is typically prescribed for those with mild to moderate hepatic dysfunction; the medication is contraindicated in patients with severe liver disease.
What if you forget to take Nirglim MV 2/0.3 Tablet SR :
Should you forget a Nirglim MV 2/0.3 Tablet SR dose, take it immediately if you remember. However, near the time for your next dose, omit the missed dose and resume your usual schedule. Never take a double dose.
Facts to Know About Nirglim MV 2/0.3 Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
